The overall objective of this proposal is to understand the cellular and molecular mechanisms subserving the endocytosis and metabolism of insulin- receptor complexes and to then determine the biological significance of these processes in insulin action. Further understanding in this area is essential for the eventual elucidation of the pathophysiology of insulin resistant states such as obesity and type II diabetes mellitus. Although receptor-mediated internalization and intracellular processing of insulin-receptor complexes are fundamental properties in all insulin target cells, at present neither the molecular mechanism nor the functional roles of these processes are well understood. The work accomplished thus far has led to identification of the general region of the human insulin receptor (hIR) intracytoplasmic domain that is important for endocytosis. Accordingly, the objective of this proposal is to contribute to further understanding in this area by pursuing the following specific aims: 1) to identify and characterize the amino acid residues (internalization domain) in the intracytoplasmic juxtamembrane region of hIR which mediate its endocytic function. 2) To determine the relationship of the internalization domain to other functional domains of the hIR beta-subunit. 3) To assess the role of the internalization of insulin-receptor complexes in insulin action using mutant hIR with altered endocytic properties. 4) To generate and characterize antipeptide monoclonal antibodies directed against the internalization domain of hIR; and 5) to use the monoclonal antibodies to explore the role of internalization in insulin action in different insulin target cells. In pursuing these aims, extensive cellular, biochemical and molecular biological methodologies will be utilized. In brief these will include cell culture, DNA cloning, mutagenesis, transfection and generation of hIR mutants, generation of monoclonal antibodies and various functional studies including endocytosis and processing of hIRs as well as measurement of several insulin-stimulated biological actions. These will include: stimulation of glucose uptake (a rapid transmembrane effect); stimulation of glycogen and protein synthesis (effects of intermediate duration); and stimulation of RNA and DNA synthesis (longer-term effects). It is expected that these studies will provide novel information that will lead to a better understanding of the mechanism of insulin action and thereby contribute to the eventual elucidation of the pathophysiology of insulin resistance, a major abnormality in obesity and type II diabetes mellitus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032880-10
Application #
2138901
Study Section
Metabolism Study Section (MET)
Project Start
1983-08-01
Project End
1996-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Berhanu, P; Anderson, C; Hickman, M et al. (1997) Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation. J Biol Chem 272:22884-90
Schranz, D B; Rohilla, A M; Anderson, C et al. (1996) Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects. Biochem Biophys Res Commun 227:600-7
Berhanu, P; Anderson, C; Paynter, D R et al. (1995) The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform. Biochem Biophys Res Commun 209:730-8
Staubs, P A; Reichart, D R; Saltiel, A R et al. (1994) Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J Biol Chem 269:27186-92
Berhanu, P; Ibrahim-Schneck, R H; Anderson, C et al. (1991) The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes. Mol Endocrinol 5:1827-35
Rohilla, A M; Anderson, C; Wood, W M et al. (1991) Insulin downregulates the steady-state level of its receptor's messenger ribonucleic acid. Biochem Biophys Res Commun 175:520-6
Berhanu, P; Rohilla, A M; Rutter, W J (1990) Replacement of the human insulin receptor transmembrane and cytoplasmic domains by corresponding domains of the oncogene product v-ros leads to accelerated internalization, degradation, and down-regulation. J Biol Chem 265:9505-11
Sassa, S (1988) Heme stimulation of cellular growth and differentiation. Semin Hematol 25:312-20